These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 22943275)

  • 1. Link between carbapenemase-producing Enterobacteria carriage and cross-border exchanges: eight-year surveillance in a large French multihospitals institution.
    Fournier S; Lepainteur M; Kassis-Chikhani N; Huang M; Brun-Buisson C; Jarlier V;
    J Travel Med; 2012; 19(5):320-3. PubMed ID: 22943275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term control of carbapenemase-producing Enterobacteriaceae at the scale of a large French multihospital institution: a nine-year experience, France, 2004 to 2012.
    Fournier S; Monteil C; Lepainteur M; Richard C; Brun-Buisson C; Jarlier V; Ap-Hp Outbreaks Control Group C
    Euro Surveill; 2014 May; 19(19):. PubMed ID: 24852956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementation of an infection control programme to limit the spread of extended-spectrum beta-lactamase-producing Enterobacteriaceae in a Belgian university hospital.
    Christiaens G; Barbier C; Warnotte J; Mutsers J
    J Hosp Infect; 2008 Apr; 68(4):366-7. PubMed ID: 18329138
    [No Abstract]   [Full Text] [Related]  

  • 4. Class D OXA-48 carbapenemase in multidrug-resistant enterobacteria, Senegal.
    Moquet O; Bouchiat C; Kinana A; Seck A; Arouna O; Bercion R; Breurec S; Garin B
    Emerg Infect Dis; 2011 Jan; 17(1):143-4. PubMed ID: 21192883
    [No Abstract]   [Full Text] [Related]  

  • 5. Characteristics and costs of carbapenemase-producing enterobacteria carriers (2012/2013).
    Daroukh A; Delaunay C; Bigot S; Ceci JM; Siddhoun N; Bukreyeva I; Raisin J; Porcheret H; Maisonneuve L; Bouldouyre MA
    Med Mal Infect; 2014 Jul; 44(7):321-6. PubMed ID: 25022890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficiency of different control measures for preventing carbapenemase-producing enterobacteria and glycopeptide-resistant
    Fournier S; Desenfant L; Monteil C; Nion-Huang M; Richard C; Jarlier V;
    Euro Surveill; 2018 Feb; 23(8):. PubMed ID: 29486831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbapenemase-producing Enterobacteriaceae: a call for action!
    Nordmann P; Cornaglia G
    Clin Microbiol Infect; 2012 May; 18(5):411-2. PubMed ID: 22507108
    [No Abstract]   [Full Text] [Related]  

  • 8. Control strategies for carbapenemase-producing Enterobacteriaceae at different levels of the healthcare system.
    Asensio Á; Cantero M; Shaw E; Vergara-López S
    Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():61-6. PubMed ID: 25542054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control strategy for carbapenemase-producing Enterobacteriaceae in nursing homes: perspectives inspired from three outbreaks.
    Legeay C; Hue R; Berton C; Cormier H; Chenouard R; Corvec S; Birgand G
    J Hosp Infect; 2019 Feb; 101(2):183-187. PubMed ID: 30389597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of carbapenemase-producing Enterobacteriaceae in a low incidence area: A six-year experience in a university hospital.
    Emery A; Jeanvoine A; Bailly P; Gbaguidi-Haore H; Hocquet D; Bertrand X
    Infect Control Hosp Epidemiol; 2019 Aug; 40(8):936-938. PubMed ID: 31203818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of carbapenemase-producing Enterobacteriaceae outbreaks in acute settings: an evidence review.
    French CE; Coope C; Conway L; Higgins JP; McCulloch J; Okoli G; Patel BC; Oliver I
    J Hosp Infect; 2017 Jan; 95(1):3-45. PubMed ID: 27890334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Carbapenemase-producing enterobacteriae: epidemiology, strategies to control their spread and issues].
    Lepelletier D; Batard E; Berthelot P; Zahar JR; Lucet JC; Fournier S; Jarlier V; Grandbastien B
    Rev Med Interne; 2015 Jul; 36(7):474-9. PubMed ID: 25600328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergence of carbapenemase-producing Enterobacteriaceae in France, 2004 to 2011.
    Vaux S; Carbonne A; Thiolet JM; Jarlier V; Coignard B;
    Euro Surveill; 2011 Jun; 16(22):. PubMed ID: 21663708
    [No Abstract]   [Full Text] [Related]  

  • 14. Is cohorting the only solution to control carbapenemase-producing Enterobacteriaceae outbreaks? A single-centre experience.
    Legeay C; Thépot-Seegers V; Pailhoriès H; Hilliquin D; Zahar JR
    J Hosp Infect; 2018 Aug; 99(4):390-395. PubMed ID: 29438727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combating the spread of carbapenemases in Enterobacteriaceae: a battle that infection prevention should not lose.
    Savard P; Perl TM
    Clin Microbiol Infect; 2014 Sep; 20(9):854-61. PubMed ID: 24980472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surveillance of extended-spectrum beta-lactamase-producing bacteria and routine use of contact isolation: experience from a three-year period.
    Kola A; Holst M; Chaberny IF; Ziesing S; Suerbaum S; Gastmeier P
    J Hosp Infect; 2007 May; 66(1):46-51. PubMed ID: 17350720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methicillin-resistant staphylococci (MRS) and extended-spectrum beta-lactamases (ESBL)-producing Enterobacteriaceae in companion animals: nosocomial infections as one reason for the rising prevalence of these potential zoonotic pathogens in clinical samples.
    Wieler LH; Ewers C; Guenther S; Walther B; Lübke-Becker A
    Int J Med Microbiol; 2011 Dec; 301(8):635-41. PubMed ID: 22000738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ESBL-producing Enterobacteriaceae: controlling the spread of infection.
    Bissett L
    Br J Nurs; 2007 Jun 14-27; 16(11):644-7. PubMed ID: 17577180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlling Nosocomial Transmission of Drug-Resistant Pathogens at Different Endemic Stages in a Resource-Limited Setting.
    Carlson AL; Pruetpongpun N; Buppajarntham A; Apisarnthanarak A
    Infect Control Hosp Epidemiol; 2016 Sep; 37(9):1114-6. PubMed ID: 27322523
    [No Abstract]   [Full Text] [Related]  

  • 20. Control of emerging extensively drug-resistant organisms (eXDRO) in France: a survey among infection preventionists from 286 healthcare facilities.
    Lepelletier D; Lucet JC; Astagneau P; Coignard B; Vaux S; Rabaud C; Grandbastien B; Berthelot P
    Eur J Clin Microbiol Infect Dis; 2015 Aug; 34(8):1615-20. PubMed ID: 25957988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.